Cost of illness, cost of immunoglobulin therapy and their determinants in chronic inflammatory demyelinating polyneuropathy

Yusuf A. Rajabally*

*Corresponding author for this work

Research output: Contribution to journalLetter, comment or opinionpeer-review

Original languageEnglish
Pages (from-to)E22
JournalMuscle and Nerve
Volume59
Issue number3
DOIs
Publication statusPublished - 1 Mar 2019

Cite this